Immutrix Therapeutics' Unattributed - II Round

Immutrix Therapeutics raised a round of funding on June 28, 2016.

ImmutriX Therapeutics developed a medical device for cleansing whole blood to modulate and sequester molecules from circulation known to be contrary to health. ImmutriX products target and bind molec…

Articles about Immutrix Therapeutics' Unattributed - II Round: